|Bid||1.3100 x 2200|
|Ask||1.3300 x 3100|
|Day's Range||1.3000 - 1.3300|
|52 Week Range||0.4100 - 3.6400|
|Beta (5Y Monthly)||3.62|
|PE Ratio (TTM)||N/A|
|Earnings Date||Aug 12, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||3.50|
MARLBOROUGH, Mass. BERLIN, Germany and YOKNEAM ILIT, Israel, Aug. 07, 2020 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced that the Company will release its second quarter 2020 financial results on Wednesday, August 12, 2020, before the U.S. financial markets open. Larry Jasinski, Chief Executive Officer, and Ori Gon, Chief Financial Officer, will host a conference call to discuss the results as follows:Time8:30 A.M EST Toll free (U.S.)(844) 423-9889 International (U.S)(716) 247-5804 Germany08 00 18 15 287 Israel18 09 31 53 62 Access Code9366548 Webcast (live and replay)https://edge.media-server.com/mmc/p/5i2w4ds5 under the ‘Investors’ section'. The archived webcast will be available via the following https://edge.media-server.com/mmc/p/5i2w4ds5 or through the 'Investors' section' on www.rewalk.com. About ReWalk Robotics Ltd.ReWalk Robotics Ltd. develops, manufactures and markets wearable robotic exoskeletons for individuals with lower limb disabilities as a result of spinal cord injury or stroke. ReWalk’s mission is to fundamentally change the quality of life for individuals with lower limb disability through the creation and development of market leading robotic technologies. Founded in 2001, ReWalk has headquarters in the U.S., Israel and Germany. For more information on the ReWalk systems, please visit www.rewalk.com.ReWalk® is a registered trademark of ReWalk Robotics Ltd. in Israel and the Unites States. Investor Contact: Ori Gon Chief Financial Officer ReWalk Robotics Ltd. T: +972-4-9590123 E: email@example.com
ReWalk (RWLK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ReWalk Robotics, Ltd. (Nasdaq: RWLK) ("ReWalk" or the "Company"), a manufacturer of robotic medical devices for individuals with lower limb disabilities, today announced the Centers for Medicare and Medicaid Services ("CMS") issued Healthcare Common Procedure Coding System ("HCPCS") Level II Code K1007 in response to the Company's application. This decision, which will be effective on October 1, 2020, establishes the first such code for exoskeletons.